CDMO – GALENIC DEVELOPMENT

Optimized, safe and compliant formulations to transform your API into a market-ready success

You aim to develop more effective and safer therapeutic solutions for human or veterinary applications, while ensuring their compliance with your regulatory requirements?

Whether it’s for registering new formulations, updating your files, or optimizing your existing products, our expertise in over 10 galenic forms – both sterile and non-sterile – is at your service to help you meet your technical and regulatory challenges.

Our formulations are designed for smooth scaling. Furthermore, we support you at every step of your manufacturing process to ensure a seamless transition to commercial production.

How can we help you?

    *These fields are required

    OUR DOSAGE FORMS FOR HUMAN OR VETERINARY USE

    We have the expertise and a proven track record in formulating a wide range of pharmaceutical products, such as:

    Sterile forms :

    • semi-solids in tubes
    • powders for injection
    • injectable solutions

    Liquid forms :

    • syrups
    • nasal sprays

    Semi-solid forms :

    • creams
    • gels
    • ointments

    Dry forms :

    • tablets
    • capsules
    • powder

    PATENTED INNOVATION ! Controlled release syrup

    We are convinced that many API still possess an unexploited potential yet to be revealed in order to accelerate therapeutic progress. The desire of our CDMO is to actively contribute to this.

    This is why our laboratory also works on the development of new technologies. Our latest unique and worldwide patent is that of MMCR (Multi-layer Microparticle Controlled Release) technology which allows the development of a controlled release syrup (sustained or delayed). A major breakthrough for pediatric populations or people with swallowing impairments.

    Learn more about MMCR technology for a controlled-release syrup

    HOW DO WE ASSIST YOU IN YOUR FORMULATION PROCESS?

    • Formulation Development: our team of scientists, specializing in various galenic forms and delivery technologies, designs and optimizes formulations tailored to the specific properties of your active substance and your target population.
    • Analytical Services: we offer comprehensive analytical services to assess the physicochemical properties, stability, and performance of your formulations. This includes the development and validation of methods in accordance with ICH guidelines, ensuring test precision and robustness.
    • Regulatory Support: our CDMO works closely with external regulatory affairs experts to prepare your submissions, ensure compliance, and accelerate time-to-market. We provide ongoing support throughout the regulatory review process.

    OUR KEY FIGURES

    10 different dosage forms
    40 different finished products
    12 years of development expertise
    2 production zones, including 1 controlled atmosphere zone (class ABCD for semi-solids in tubes, powders and solutions for injection in vials)

    1 area dedicated to clinical batches, regulatory batches, and small commercial batches
    110 employees (R&D, production, and analytical services)
    6000 m² total area